Empagliflozin Reduced Cardiovascular Events and Mortality in Type 2 DiabetesEmpagliflozin降低了2型糖尿病心血管事件和死亡率该条目提交于 健康 心血管病 并标识为 Cardiovascular Events Empagliflozin Mortality Type 2 Diabetes; 2型糖尿病 心血管事件 死亡率 分钟 19 9 月, 2015 通过hyangiu A randomized trial showed that empagliflozin (Jard […] Share this:TwitterFacebookLinkedInEmailPrintMoreRedditTumblrPocketPinterestTelegramWhatsAppLike this:Like Loading...
